Cost-cutting X4 chops head count by 50%, lays off execs in mission to complete Xolremdi expansion study
17th September 2025 Uncategorised 0It’s the second restructuring this year for X4 Pharmaceuticals as the company moves forward under new leadership and with 50% fewer staff members.
More: Cost-cutting X4 chops head count by 50%, lays off execs in mission to complete Xolremdi expansion study
Source: fierce